GHKCu is a naturally occurring copper peptide that upregulates collagen I and III, elastin, glycosaminoglycans, and wound-healing pathways while shifting gene expression toward a more youthful pattern and reducing inflammation and oxidative damage
The depletion of brain GSH has also been observed from both autopsies as well as in vivo MRS studies with aging and varied neurological disorders (Alzheimers disease, Parkinsons disease, etc.)
For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog
The GHK-Cu safety profile is strong when you apply a high-quality topical serum